Bioequivalence Study of Test and Reference 400 mg Ibuprofen Coated Tablets in Healthy Volunteers

Clinical trial NCT05663398 · COMPLETED

Trial details

NCT number: NCT05663398
Sponsor: Darnitsa Pharmaceutical Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bioequivalence Healthy Subjects

Start date: 2022-05-17
Primary completion: 2022-05-31
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.